Clinical Trial Update: Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety and tolerability of XmAb7195 in healthy adults and adults with allergic rhinitis, allergic conjunctivitis, or atopic dermat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Atopic Dermatitis

Drugs mentioned

• XmAb7195

Snippet

Sponsor: Xencor, Inc. | Conditions: Allergic Rhinitis, Allergic Conjunctivitis | Phase 1 | Status: COMPLETED